Centre Issues New Guidelines To Check Malpractice In Stem Cell Treatment
- According to newly released National Guidelines on the Stem Cell Research, the usage of stem cell on patients will be considered as a research, and not a treatment.
- A use of stem cells for patients that are not approved for clinical trials will be considered as a malpractice. Now, there are good chances of curbing down the malpractice of stem cell ‘treatment’, which were being offered as latest tool to cure fatal diseases.
- The stem cells should be used in patients within the scope of the approved and well monitored medical trials. It should be done with intent to develop the medicine and science, and not to be provides as any treatment.
- There might be no guidelines for stem cell treatment, until and unless its efficacy is proven. The new guidelines are designed to cover up the research on stem cell. They point out that the technology of using stem cells in patients, except on hematopoietic stem cell reconstitution, is still fairly new at present.
- Stem Cells
- National Guidelines on the Stem Cell Research